| Assay | Organism tested | Dose/concentration | Molecular targets | References |
| Free radical-scavenging activity | | 1, 3, 10, 30, 100, or 300 µg/mL | | [107] | Inhibitory activity against autophagy-associated airway epithelial fibrosis | Mice | 1–20 M | E-cadherin┴, vimentin┴, Beclin-1↓, LC3A/B↓, EMT↓, and TGF-β1┴ | [132] | Apoptotic and eosinophilia amelioration | BEAS-2B cells | 1–20 M | TLR-4↓, Eotaxin-1↓, PLCγ1↓, PKCβ2↓, p-p22↓, p-47↓, JNK↓, p38 MAPK↓, Akt↑, and ERK↑ | [129] | Suppression of 6-hydroxydopamine-induced neurotoxicity in Caenorhabditis elegans | C. elegans | 2.0 mg/mL | egl-1↓, SOD↑, GPX↑, AChe↑, and p38 MAPK↓ | [130] | Neuroprotective effect against ischemic brain injury | Wister rats | 5 mg/kg and 15 mg/kg | NCam↑ | [131] |
|
|